Market Need Therapeutic focus on preventing Campylobacter in poultry and broader bacterial infections suggests sales opportunities with poultry producers, meat processors, and animal health distributors seeking food safety and infection control solutions.

Early Stage Financing Recent $4.4M financing and total funding of $6.3M indicate readiness to engage co-investors or strategic partners for scale-up, potential venture collaborations, and milestone-driven partnerships.

Strategic Partnerships Existing partnerships with Banham Poultry highlight openness to B2B collaborations; target similar poultry producers, feed manufacturers, and biosecurity service providers for joint product adoption.

Technology Edge Fe3C-based broad-spectrum antibacterial approach plus silk biomaterial licensing offer defensible differentiators; explore licensing deals or co-development with animal health formulators and feed additive companies.

Market Readiness Small team size implies flexibility but limited field execution; prioritize pilot programs, distributor recruitment, and contractual pilots with clear milestones to accelerate market entry in EU/US markets.